[
    {
        "article_link": "https://www.frontiersin.org/articles/10.3389/fcell.2021.649265/full",
        "data": [
            {
                "id": "data_1",
                "omics": "Transcriptomics",
                "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163574",
                "format": "txt",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE163574"
            },
            {
                "id": "data_2",
                "omics": "Proteomics",
                "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023344",
                "format": "raw",
                "source": "ProteomeXchange",
                "public_id": "PXD023344"
            },
            {
                "id": "data_3",
                "omics": "Phosphoproteomics",
                "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023345",
                "format": "raw",
                "source": "ProteomeXchange",
                "public_id": "PXD023345"
            },
            {
                "id": "data_4",
                "omics": "Transcriptomics",
                "link": "",
                "format": "",
                "source": "The Cancer Genome Atlas (TCGA)",
                "public_id": "TCGA_PAAD"
            },
            {
                "id": "data_5",
                "omics": "Transcriptomics",
                "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62452",
                "format": "txt",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE62452"
            },
            {
                "id": "data_6",
                "omics": "Transcriptomics",
                "link": "",
                "format": "",
                "source": "International Cancer Genome Consortium (ICGC)",
                "public_id": "ICGC_AU"
            }
        ],
        "analyses": [
            {
                "id": "analysis_1",
                "analysis_name": "Transcriptomics",
                "analysis_data": [
                    "data_1"
                ],
                "label": {
                    "Treatment": [
                        "anlotinib",
                        "DMSO"
                    ]
                }
            },
            {
                "id": "analysis_2",
                "analysis_name": "Differential analysis",
                "analysis_data": [
                    "data_1"
                ],
                "label": {
                    "Fold change": [
                        ">=2"
                    ],
                    "FDR": [
                        "<0.05"
                    ]
                }
            },
            {
                "id": "analysis_3",
                "analysis_name": "Pathway analysis",
                "analysis_data": [
                    "analysis_2"
                ],
                "label": null
            },
            {
                "id": "analysis_4",
                "analysis_name": "Proteomics",
                "analysis_data": [
                    "data_2"
                ],
                "label": {
                    "Treatment": [
                        "anlotinib",
                        "DMSO"
                    ]
                }
            },
            {
                "id": "analysis_5",
                "analysis_name": "Differential analysis",
                "analysis_data": [
                    "data_2"
                ],
                "label": {
                    "Fold change": [
                        ">1.2"
                    ],
                    "p-value": [
                        "<0.05"
                    ]
                }
            },
            {
                "id": "analysis_6",
                "analysis_name": "Pathway analysis",
                "analysis_data": [
                    "analysis_5"
                ],
                "label": null
            },
            {
                "id": "analysis_7",
                "analysis_name": "Phosphoproteomics",
                "analysis_data": [
                    "data_3"
                ],
                "label": {
                    "Treatment": [
                        "anlotinib",
                        "DMSO"
                    ]
                }
            },
            {
                "id": "analysis_8",
                "analysis_name": "Differential analysis",
                "analysis_data": [
                    "data_3"
                ],
                "label": {
                    "Fold change": [
                        ">1.2"
                    ],
                    "p-value": [
                        "<0.05"
                    ]
                }
            },
            {
                "id": "analysis_9",
                "analysis_name": "Pathway analysis",
                "analysis_data": [
                    "analysis_8"
                ],
                "label": null
            },
            {
                "id": "analysis_10",
                "analysis_name": "Classification analysis",
                "analysis_data": [
                    "analysis_2",
                    "data_4",
                    "data_5",
                    "data_6"
                ],
                "label": {
                    "Risk score": [
                        "high",
                        "low"
                    ]
                }
            },
            {
                "id": "analysis_11",
                "analysis_name": "Regression analysis",
                "analysis_data": [
                    "analysis_10"
                ],
                "label": null
            },
            {
                "id": "analysis_12",
                "analysis_name": "Gene co-expression network analysis",
                "analysis_data": [
                    "analysis_10"
                ],
                "label": null
            }
        ],
        "results": [
            {
                "analysis_id": "analysis_2",
                "metrics": "Number of differentially expressed genes",
                "value": "992",
                "features": null
            },
            {
                "analysis_id": "analysis_3",
                "metrics": "Enriched pathways",
                "value": "24 cancer-related canonical pathways",
                "features": [
                    "Unfolded protein response",
                    "Cell cycle: G2/M DNA damage checkpoint regulation",
                    "Cell cycle control of chromosomal replication",
                    "Role of BRCA1 in DNA damage response"
                ]
            },
            {
                "analysis_id": "analysis_5",
                "metrics": "Number of differentially expressed proteins",
                "value": "1046",
                "features": null
            },
            {
                "analysis_id": "analysis_6",
                "metrics": "Enriched pathways",
                "value": "Ribosome, Lysosome",
                "features": [
                    "LAPM1",
                    "LAMP2",
                    "44 ribosome-related proteins"
                ]
            },
            {
                "analysis_id": "analysis_8",
                "metrics": "Number of differentially phosphorylated proteins",
                "value": "1753",
                "features": null
            },
            {
                "analysis_id": "analysis_9",
                "metrics": "Enriched pathways",
                "value": "RNA transport, Spliceosome, Cell cycle, Regulation of actin cytoskeleton, mTOR signaling",
                "features": null
            },
            {
                "analysis_id": "analysis_10",
                "metrics": "AUC",
                "value": "0.7 (3 years), 0.72 (5 years)",
                "features": [
                    "TOP2A",
                    "CRABP2",
                    "CDK1",
                    "NUSAP1",
                    "PERP"
                ]
            },
            {
                "analysis_id": "analysis_10",
                "metrics": "Proportion in high-risk subgroup",
                "value": "57%",
                "features": null
            },
            {
                "analysis_id": "analysis_11",
                "metrics": "Hazard Ratio (HR)",
                "value": "2.318",
                "features": null
            },
            {
                "analysis_id": "analysis_12",
                "metrics": "Enriched pathways in high-risk subgroup",
                "value": "33 pathways",
                "features": [
                    "Cell cycle",
                    "Spliceosome",
                    "DNA replication",
                    "RNA degradation",
                    "DNA damage repair",
                    "p53 signaling pathway"
                ]
            }
        ]
    }
]